How Many Months Should You Take Semaglutide?

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

There is no one-size-fits-all answer to how long you should take semaglutide. Most clinical trials show meaningful weight loss results within 3 to 6 months, though individual timelines depend on your starting weight, metabolic health, and personal goals. PlexusDx uses precision genetic testing to help provide pathway-level context (it does not predict your response) and guide your treatment plan.

Typical Semaglutide Treatment Duration and Timeline

Clinical research demonstrates that most people taking semaglutide see measurable results between weeks 8 and 16 of consistent use. The medication works by slowing stomach emptying and increasing feelings of fullness, which typically requires several weeks of steady dosing before the full effect appears. Your body gradually adapts to the medication, and appetite suppression typically deepens over the first 3 to 4 months of treatment.

Beyond the initial 6-month window, many patients continue semaglutide therapy for 12 months or longer if they are meeting their weight loss targets and tolerating the medication well. Studies suggest that stopping semaglutide before reaching your goal often leads to gradual weight regain within months. For this reason, gastroenterologists and weight loss specialists typically recommend staying on the medication until you achieve your target weight and have developed sustainable eating habits.

Some patients benefit from semaglutide for 18 to 24 months or more, particularly those with significant weight loss goals or metabolic challenges. Your treatment length should be decided in partnership with your healthcare provider based on your response, tolerance, and changing health priorities.

When to Consider Stopping Semaglutide: Exit Strategies

Stopping semaglutide is most successful when you have achieved your weight loss goal and established new eating behaviors that support long-term weight stability. Research shows that patients who stop the medication while still at their highest weight experience faster weight regain. Ideally, you should plan to maintain your target weight for at least 1 to 2 months on semaglutide before discussing discontinuation with your provider.

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Certain life circumstances, such as pregnancy, severe illness, or major medication changes, may require stopping semaglutide sooner than planned. Always consult your healthcare provider before discontinuing therapy, as abrupt cessation can trigger hunger signals and unplanned weight gain within weeks.

How Genetic Testing Personalizes Your Semaglutide Timeline

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Semaglutide Compounded Injections at PlexusDx: Consistent Dosing Over Time

PlexusDx offers Compounded Semaglutide Injection from licensed 503A compounding pharmacies, at $189/mo month-to-month, or from $149/mo on the 6-month plan across all commitment tiers. Unlike brand-name semaglutide, PlexusDx's compounded option provides flexible, personalized dosing that can be adjusted monthly as your weight loss journey progresses. Your dose may need to go up as your body adapts, but your price stays flat—removing the financial uncertainty from extended treatment.

Whether your semaglutide timeline is 3 months, 12 months, or longer, PlexusDx maintains consistent monthly pricing with no insurance required and HSA/FSA eligibility. Customers across all 50 states can access treatment without membership fees. After your first month of therapy, you can add the Precision Peptide Genetic Test ($298) to refine your personalized timeline and optimize outcomes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How do I know if I should stop semaglutide after reaching my weight loss goal?

You should discuss discontinuation with your healthcare provider once you have reached your target weight and maintained it for 1 to 2 months on semaglutide. Many providers recommend a gradual dose reduction rather than immediate stopping to minimize rebound weight gain. PlexusDx's genetic testing can help identify whether your metabolic profile suggests you benefit from extended maintenance therapy or can safely stop sooner.

What does research say about weight regain after stopping semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I use PlexusDx semaglutide for 6 months and then stop?

Yes, many patients successfully use semaglutide for 6 months and discontinue if they achieve their goals and maintain new eating patterns. However, some individuals need 12+ months based on their starting weight and metabolism. PlexusDx Compounded Semaglutide Injection costs only $189/month regardless of treatment length, so you can extend or shorten your timeline without financial penalty.

Is it safe to stay on semaglutide for a year or longer?

Long-term semaglutide use (12+ months) has been studied and shows sustained safety and efficacy for weight loss maintenance in clinical trials. Your provider should monitor your health regularly, especially kidney function and thyroid health. Extended therapy is appropriate for many patients, particularly those with obesity-related conditions or strong genetic predisposition to weight regain.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437) and FTO (rs9939609)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide Providers That Take Fsa Plexusdx
• Medvi Semaglutide
• Bioverse Semaglutide
• Ro Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.